Center-Authored Papers

Filters: Author is Stanton, Sasha E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Marquez JP, Stanton SE, Disis ML.  2015.  The Antigenic Repertoire of Premalignant and High-Risk Lesions.. Cancer prevention research (Philadelphia, Pa.). 8(4):266-270. Abstract
B
Stanton SE, Davidson NE.  2017.  Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer? Nature reviews. Clinical oncology.
C
Disis ML, Stanton SE.  2013.  Can immunity to breast cancer eliminate residual micrometastases? Clinical cancer research : an official journal of the American Association for Cancer Research. 19(23):6398-403. Abstract
Stanton SE, Disis ML.  2016.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer.. Journal for immunotherapy of cancer. 4:59. Abstract
Stanton SE, Eary JF, Marzbani EA, Mankoff D, Salazar LG, Higgins D, Childs J, Reichow J, Dang Y, Disis ML.  2016.  Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo.. Journal for immunotherapy of cancer. 4:27. Abstract
Cherryholmes GA, Stanton SE, Disis ML.  2015.  Current methods of epitope identification for cancer vaccine design.. Vaccine. Abstract
D
Stanton SE, Disis ML.  2015.  Designing vaccines to prevent breast cancer recurrence or invasive disease.. Immunotherapy. 7(2):69-72.
I
Disis ML, Stanton SE.  2017.  Immunotherapy in breast cancer: An introduction.. Breast (Edinburgh, Scotland). Abstract
M
Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E et al..  2014.  Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.. Journal of translational medicine. 12(1):121. Abstract
V
Stanton SE, Adams S, Disis ML.  2016.  Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.. JAMA oncology. Abstract